Skip to main content
Top
Published in: Respiratory Research 1/2021

Open Access 01-12-2021 | Pneumonia | Research

The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study

Authors: Jun Wen, Yufei Su, Hongli Sun, Huiping Zhang, Hui Li

Published in: Respiratory Research | Issue 1/2021

Login to get access

Abstract

Objective

Thise study is aimed to identify the biomarkers for predicting refractory Mycoplasma pneumoniae pneumonia in Chinese children at the time of the hospital admission.

Methods

The case control study retrospectively analyzed the clinical characteristics and laboratory results of Chinese pediatric patients presenting with common and refractory Mycoplasma pneumoniae pneumonia (CMPP and RMPP). Overall, there were 216 cases in the CMPP group and 88 cases in the RMPP group. Venous blood was collected, and serum ferritin (SF), lactate dehydrogenase (LDH), D-dimer, C-reactive protein (CRP), procalcitonin (PCT), neutrophil count/lymphocyte count (NLR), and other indexes were measured. A single factor analysis, an ROC curve analysis, and a logistic regression analysis were used to determine the independent risk factors of RMPP and find combination of initial markers for RMPP.

Results

There were significant differences between the RMPP group and the CMPP group in mean SF (529.82 [357.86] vs. 147.22 [122.68] ng/mL), LDH (522.08 [389.08] vs. 286.85 [101.02] U/L), D-dimer (6.65 [5.66] vs. 1.46 [2.45] μg/mL), CRP (62.80 [52.15] vs. 19.03 [24.50] mg/L), PCT (0.80 [2.61] vs. 0.16 [0.44]) ng/mL, and NLR (4.14 [2.52] vs. 2.62 [1.55]), with P < 0.05 for each comparison. ROC cut-off values of the above indexes were 329.01 ng/mL, 375.50 U/L, 2.10 μg/mL, 43.08 mg/L, 0.08 ng/mL, and 2.96, respectively. The logistic regression analysis showed that SF, D-dimer, and CRP are independent risk factors to predict RMPP.

Conclusion

SF, D-dimer, and CRP are statistically significant biomarkers to predict RMPP in Chinese children patients in the settings of pediatric emergency department.
Literature
4.
go back to reference Respiratory Section, Chinese Medical Association of Pediatrics. Expert consensus on diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. Chin J Pract Clin Pediatr. 2015;30(17):1304–08. Respiratory Section, Chinese Medical Association of Pediatrics. Expert consensus on diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. Chin J Pract Clin Pediatr. 2015;30(17):1304–08.
8.
go back to reference Respiratory Section, Chinese Medical Association of Pediatrics, Editorial Board. Guidelines on community-based pneumonia management for children (2013 Revision) (I). Chin J Pediatr. 2013;51(10):745–52. Respiratory Section, Chinese Medical Association of Pediatrics, Editorial Board. Guidelines on community-based pneumonia management for children (2013 Revision) (I). Chin J Pediatr. 2013;51(10):745–52.
12.
go back to reference Liu X, Cui Z, Yang G. Analysis of risk factors of refractory Mycoplasma pneumoniae pneumonia. Chin J Mode Med. 2020;30(2):55–9. Liu X, Cui Z, Yang G. Analysis of risk factors of refractory Mycoplasma pneumoniae pneumonia. Chin J Mode Med. 2020;30(2):55–9.
13.
go back to reference Liu Y. Evaluation of clinical efficacy of fiberoptic bronchoscopy in the diagnosis and treatment of refractory Mycoplasma pneumoniae pneumonia complicated with atelectasis in children. Int Infect Dis. 2019;8(3):82. Liu Y. Evaluation of clinical efficacy of fiberoptic bronchoscopy in the diagnosis and treatment of refractory Mycoplasma pneumoniae pneumonia complicated with atelectasis in children. Int Infect Dis. 2019;8(3):82.
14.
go back to reference Yue TZ. Advances in research on common long-term complications of Mycoplasma pneumoniae pneumonia. Int J Pediatr. 2019;46(1):36–9. Yue TZ. Advances in research on common long-term complications of Mycoplasma pneumoniae pneumonia. Int J Pediatr. 2019;46(1):36–9.
19.
go back to reference Wang Z, Li YC, Chen L. Early identification of refractory Mycoplasma pneumoniae pneumonia in children. Zhongguo Dang Dai ErKeZaZhi. 2015;17(11):1189–92. Wang Z, Li YC, Chen L. Early identification of refractory Mycoplasma pneumoniae pneumonia in children. Zhongguo Dang Dai ErKeZaZhi. 2015;17(11):1189–92.
20.
go back to reference Chen L, Liu J, Zhao S, et al. Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponsive to conventional dose methylprednisolone in children. ZhonghuaErKeZaZhi. 2014;52(3):172–6. Chen L, Liu J, Zhao S, et al. Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponsive to conventional dose methylprednisolone in children. ZhonghuaErKeZaZhi. 2014;52(3):172–6.
21.
go back to reference Xu JJ, Shu LH. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children. Zhongguo Dang Dai ErKeZaZhi. 2018;20(1):37–42. Xu JJ, Shu LH. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children. Zhongguo Dang Dai ErKeZaZhi. 2018;20(1):37–42.
23.
go back to reference Liu JR, Peng Y, Yang HM, et al. Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia. ZhonghuaErKeZaZhi. 2012;50(12):915–8. Liu JR, Peng Y, Yang HM, et al. Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia. ZhonghuaErKeZaZhi. 2012;50(12):915–8.
26.
go back to reference Chen Q. Clinical significance of combined detection of D-dimer and LDH, CRP, ESR in children with mycoplasma pneumonia. China Matern Child Health Care. 2017;32(16):3813–5. Chen Q. Clinical significance of combined detection of D-dimer and LDH, CRP, ESR in children with mycoplasma pneumonia. China Matern Child Health Care. 2017;32(16):3813–5.
27.
go back to reference Zhang Z. Value of platelet and D-dimer in patients with refractory mycoplasma pneumonia. J Lab LabSci. 2019;37(6):1129–31. Zhang Z. Value of platelet and D-dimer in patients with refractory mycoplasma pneumonia. J Lab LabSci. 2019;37(6):1129–31.
Metadata
Title
The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study
Authors
Jun Wen
Yufei Su
Hongli Sun
Huiping Zhang
Hui Li
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Pneumonia
Published in
Respiratory Research / Issue 1/2021
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01577-9

Other articles of this Issue 1/2021

Respiratory Research 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine